By Fineline Cube The National Health Commission of China (NHC) released the Statistical Bulletin on Health Development in China in 2025, indicating notable progress in the country’s health and medical work. The bulletin shows China’s average life expectancy reaching 79.25 years, continued declines in maternal and infant mortality, and total health expenditure climbing to 9,336.72 billion yuan — equivalent to 6.7% of GDP — as the world’s second-largest healthcare market continues to expand.
Key Health Indicators – 2025
| Indicator | 2025 Level | Direction |
|---|---|---|
| Average life expectancy | 79.25 years | Rising |
| Maternal mortality rate | 13.4 per 100,000 | Declining |
| Infant mortality rate | 3.8 per 1,000 | Declining |
The headline population-health metrics underscore steady gains in China’s healthcare outcomes, with all three indicators moving in favor of improved longevity and reduced mortality by the end of 2025.
Healthcare Infrastructure & Utilization
| Metric | 2025 | YoY Change |
|---|---|---|
| Total medical & health institutions | 1,108,335 | +14,784 |
| Hospitals | 38,159 | −551 |
| Outpatient & emergency visits | 10.65 billion | +510 million |
| Inpatient admissions | 299.107 million | −12.813 million |
| Average inpatient expense per stay | 9,768.9 yuan | −1.0% |
The NHC data paints a picture of a system in structural transition: the institutional footprint kept expanding while the hospital count contracted slightly, pointing to ongoing consolidation. Outpatient and emergency demand grew sharply, even as inpatient admissions declined and the average cost per hospital stay edged lower — consistent with policy efforts to contain costs and shift care toward outpatient and primary-care settings.
Health Expenditure – 2025
| Component | Amount (billion yuan) | Share of Total |
|---|---|---|
| Government health expenditure | 2,349.96 | 25.2% |
| Social health expenditure | 4,455.67 | 47.7% |
| Out-of-pocket health expenditure | 2,531.09 | 27.1% |
| Total health expenditure | 9,336.72 | 100% |
Per capita total health expenditure reached 6,637.9 yuan, with total health expenditure standing at 6.7% of GDP. Social health expenditure — dominated by social insurance schemes — remains the largest funding pillar, while the out-of-pocket share of 27.1% reflects the continued policy focus on reducing the direct financial burden on patients.
Market Impact & Outlook
- Market Scale: Health spending of 9,336.72 billion yuan at 6.7% of GDP confirms China’s healthcare market remains on a structural growth path, with room to converge toward the higher GDP shares seen in developed economies
- Cost Containment: Falling average inpatient costs and declining admissions suggest reimbursement reform and hospital consolidation are reshaping provider economics
- Demand Shift: A 510 million increase in outpatient and emergency visits signals rising volume in ambulatory care — a tailwind for outpatient services, diagnostics, and primary-care infrastructure
- Funding Mix: With social and government sources covering roughly 73% of spending, payer-driven procurement and insurance reimbursement policy will remain the decisive commercial factors for pharmaceutical and device companies operating in China
Forward‑Looking Statements – This brief summarizes official statistical data released by the National Health Commission of China. Figures marked as preliminary estimates may be revised. Content is for informational purposes only and is not investment advice.-Fineline Info & Tech